GlassScriptPhysician profile
Jena Ann Meyer
NPI 1326782947
$3,442.87
in general payments reported to CMS, 2019-2025
16 companies · $1,006 in 2025
The $1,006 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $631 · 2023: $472 · 2024: $1,334 · 2025: $1,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,786 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,786.44 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $892.04 | 2022-2025 | Oxervate |
| Biotissue Holdings INC. | $621.42 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $472.89 | 2023-2025 | Cequa |
| Bausch & Lomb Americas INC. | $423.63 | 2022-2025 | Miebo, Xiidra, Envista Envy Iol |
| Abbvie INC. | $277.50 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $224.36 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $174.17 | 2024-2025 | Kxl System, Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Coopervision INC. | $98.68 | 2024 | Paragon Crt |
| Rxsight INC | $52.62 | 2024-2025 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Alcon Vision LLC | $42.25 | 2025 | Tryptyr, Eysuvis |
| Merz Pharmaceuticals, LLC | $36.16 | 2025 | Xeomin |
| Carl Zeiss Meditec, INC. | $33.00 | 2022 | |
| Apellis Pharmaceuticals, INC. | $27.28 | 2025 | Syfovre |
| Thea Pharma INC. | $23.55 | 2023 | Iyuzeh |
| Mallinckrodt Hospital Products INC. | $22.73 | 2023 | Acthar |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $20.59 | 2024 | Ryzumvi, Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jena Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.